Nanjing King-Friend Biochemical Pharmaceutical Co Ltd Sustainability Reports
The company engages in the research, development, production, and sale of biochemical pharmaceutical products, specializing in high-end sterile injectables and heparin active pharmaceutical ingredients.
Sector: Manufacturing
Country: China
Exchange: Shanghai Stock Exchange
FIGI: BBG001TXXHD5
2 reports from 2024 to 2025
